Breaking News

Financial Report: INC Research

February 25, 2016

Revenues up 23% in the quarter

INC Research
4Q Revenues:
$402.9 million (+23%)

4Q Earnings: $30.7 million (loss of $53.2 million 4Q14)

FY Revenues: $1.4 billion (+19%)

FY Earnings: $117 million (loss of $23.5 million FY14)

Comments: Book-to-bill was 1.2x for the quarter and 1.3x for the year. Net new business awards were $297.4 million in the quarter and $1.18 billion for the year.
Revenue growth during both the fourth quarter and fiscal year 2015 was driven primarily by continued strong awards over the last two years, a lower cancellation rate of previously awarded business and a positive revenue mix. In 2015, revenue grew across all therapeutic areas and was particularly strong in complex therapeutic areas.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks